Top compounds associated with response to SIGLEC1


Feature Type Standardized
Nominal ANOVA
mRNA Crizotinib CCLE pan-cancer AAC -0.016 0.7
mRNA SJ-172550 CTRPv2 pan-cancer AAC -0.013 0.7
mRNA JNK Inhibitor VIII GDSC1000 pan-cancer AAC -0.012 0.7
mRNA tosedostat CTRPv2 pan-cancer AAC 0.012 0.7
mRNA ISOX:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.012 0.7
mRNA Nilotinib FIMM pan-cancer AAC 0.068 0.7
mRNA cyanoquinoline 11 CTRPv2 pan-cancer AAC 0.017 0.7
mRNA MLN2238 CTRPv2 pan-cancer AAC 0.011 0.7
mRNA BRD-K34485477 CTRPv2 pan-cancer AAC 0.025 0.7
mRNA CR-1-31B CTRPv2 pan-cancer AAC 0.011 0.7
Download CSV